

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA synthesis involved in DNA repair (GO:0000731) | 6.34524330 |
| 2 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 6.19972710 |
| 3 | fatty acid elongation (GO:0030497) | 5.46698308 |
| 4 | DNA deamination (GO:0045006) | 5.40960617 |
| 5 | L-methionine salvage (GO:0071267) | 5.25580466 |
| 6 | L-methionine biosynthetic process (GO:0071265) | 5.25580466 |
| 7 | amino acid salvage (GO:0043102) | 5.25580466 |
| 8 | cell wall macromolecule metabolic process (GO:0044036) | 5.02144037 |
| 9 | regulation of regulatory T cell differentiation (GO:0045589) | 4.91869701 |
| 10 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class | 4.91402843 |
| 11 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 4.72132470 |
| 12 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 4.69292829 |
| 13 | negative regulation of B cell mediated immunity (GO:0002713) | 4.69292829 |
| 14 | axoneme assembly (GO:0035082) | 4.61005166 |
| 15 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254) | 4.60244530 |
| 16 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 4.18400968 |
| 17 | cardiolipin metabolic process (GO:0032048) | 4.16493782 |
| 18 | pyrimidine dimer repair (GO:0006290) | 4.13871562 |
| 19 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 4.04555493 |
| 20 | termination of RNA polymerase III transcription (GO:0006386) | 4.04555493 |
| 21 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 3.83761654 |
| 22 | methionine biosynthetic process (GO:0009086) | 3.83037538 |
| 23 | positive regulation of lamellipodium assembly (GO:0010592) | 3.74442703 |
| 24 | synaptonemal complex organization (GO:0070193) | 3.72044832 |
| 25 | negative regulation of DNA recombination (GO:0045910) | 3.69631834 |
| 26 | cytidine metabolic process (GO:0046087) | 3.68766582 |
| 27 | cytidine catabolic process (GO:0006216) | 3.68766582 |
| 28 | cytidine deamination (GO:0009972) | 3.68766582 |
| 29 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.62080555 |
| 30 | synaptonemal complex assembly (GO:0007130) | 3.61938633 |
| 31 | tolerance induction (GO:0002507) | 3.61762757 |
| 32 | aspartate family amino acid biosynthetic process (GO:0009067) | 3.58634116 |
| 33 | glucosamine-containing compound catabolic process (GO:1901072) | 3.55860735 |
| 34 | regulation of helicase activity (GO:0051095) | 3.55651182 |
| 35 | response to pheromone (GO:0019236) | 3.52662965 |
| 36 | regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253) | 3.52060438 |
| 37 | aspartate family amino acid catabolic process (GO:0009068) | 3.51432628 |
| 38 | regulation of coenzyme metabolic process (GO:0051196) | 3.50311358 |
| 39 | regulation of cofactor metabolic process (GO:0051193) | 3.50311358 |
| 40 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 3.42383721 |
| 41 | negative regulation of interleukin-1 beta production (GO:0032691) | 3.36322895 |
| 42 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.35813265 |
| 43 | negative regulation of signal transduction by p53 class mediator (GO:1901797) | 3.30503428 |
| 44 | methionine metabolic process (GO:0006555) | 3.28231192 |
| 45 | immunoglobulin mediated immune response (GO:0016064) | 3.26526675 |
| 46 | negative regulation of neurotransmitter transport (GO:0051589) | 3.24228764 |
| 47 | negative regulation of T cell apoptotic process (GO:0070233) | 3.22626877 |
| 48 | peptidyl-histidine modification (GO:0018202) | 3.15238602 |
| 49 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.14197341 |
| 50 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 3.13706237 |
| 51 | positive regulation of mitochondrial fission (GO:0090141) | 3.12622163 |
| 52 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.11555939 |
| 53 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.11331843 |
| 54 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.09700985 |
| 55 | positive regulation of B cell differentiation (GO:0045579) | 3.09458011 |
| 56 | leukocyte aggregation (GO:0070486) | 3.07358252 |
| 57 | neuronal action potential propagation (GO:0019227) | 3.04581516 |
| 58 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.95955314 |
| 59 | proteasome assembly (GO:0043248) | 2.95799815 |
| 60 | base-excision repair, AP site formation (GO:0006285) | 2.94926794 |
| 61 | regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902108) | 2.94660448 |
| 62 | platelet dense granule organization (GO:0060155) | 2.94135062 |
| 63 | negative regulation of interleukin-1 production (GO:0032692) | 2.92431347 |
| 64 | dicarboxylic acid catabolic process (GO:0043649) | 2.84801972 |
| 65 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 2.84764444 |
| 66 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 2.84764444 |
| 67 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.84333072 |
| 68 | positive regulation of tolerance induction (GO:0002645) | 2.83916206 |
| 69 | DNA double-strand break processing (GO:0000729) | 2.83064971 |
| 70 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.81784015 |
| 71 | negative regulation of protein acetylation (GO:1901984) | 2.79694631 |
| 72 | positive regulation of lamellipodium organization (GO:1902745) | 2.78982027 |
| 73 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.69343564 |
| 74 | aspartate family amino acid metabolic process (GO:0009066) | 2.67803179 |
| 75 | sulfur amino acid biosynthetic process (GO:0000097) | 2.67782166 |
| 76 | aldehyde catabolic process (GO:0046185) | 2.66229477 |
| 77 | positive regulation of protein homodimerization activity (GO:0090073) | 2.64895344 |
| 78 | regulation of glucokinase activity (GO:0033131) | 2.63871541 |
| 79 | regulation of hexokinase activity (GO:1903299) | 2.63871541 |
| 80 | protein prenylation (GO:0018342) | 2.63082616 |
| 81 | prenylation (GO:0097354) | 2.63082616 |
| 82 | glycosphingolipid biosynthetic process (GO:0006688) | 2.58667974 |
| 83 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.57319949 |
| 84 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.54886220 |
| 85 | negative regulation of peptidyl-lysine acetylation (GO:2000757) | 2.53843951 |
| 86 | regulation of chronic inflammatory response (GO:0002676) | 2.53494465 |
| 87 | inositol phosphate dephosphorylation (GO:0046855) | 2.52175643 |
| 88 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.52175643 |
| 89 | isoprenoid biosynthetic process (GO:0008299) | 2.51216454 |
| 90 | epithelial cilium movement (GO:0003351) | 2.48587940 |
| 91 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.48409490 |
| 92 | single strand break repair (GO:0000012) | 2.46646034 |
| 93 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 2.46209380 |
| 94 | negative regulation of membrane potential (GO:0045837) | 2.46115508 |
| 95 | negative regulation of mast cell activation (GO:0033004) | 2.45746603 |
| 96 | positive regulation of G1/S transition of mitotic cell cycle (GO:1900087) | 2.42244283 |
| 97 | carnitine metabolic process (GO:0009437) | 2.41976297 |
| 98 | histone H2A ubiquitination (GO:0033522) | 2.40976966 |
| 99 | ganglioside metabolic process (GO:0001573) | 2.40957371 |
| 100 | positive T cell selection (GO:0043368) | 2.40097210 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 4.66660572 |
| 2 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 4.00491807 |
| 3 | IGF1R_20145208_ChIP-Seq_DFB_Human | 3.70460311 |
| 4 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.88519061 |
| 5 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.76560775 |
| 6 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.51608655 |
| 7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.33806415 |
| 8 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.29051430 |
| 9 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.27819792 |
| 10 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.23873017 |
| 11 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.09354834 |
| 12 | GATA1_22025678_ChIP-Seq_K562_Human | 2.03415525 |
| 13 | ER_23166858_ChIP-Seq_MCF-7_Human | 2.02986283 |
| 14 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.96434697 |
| 15 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.88071218 |
| 16 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.86930315 |
| 17 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.79010800 |
| 18 | EWS_26573619_Chip-Seq_HEK293_Human | 1.78339322 |
| 19 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.77183760 |
| 20 | VDR_22108803_ChIP-Seq_LS180_Human | 1.71786529 |
| 21 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.68257779 |
| 22 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.67713071 |
| 23 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.64884889 |
| 24 | RBPJ_21746931_ChIP-Seq_IB4_Human | 1.64784989 |
| 25 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.60025097 |
| 26 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.58823783 |
| 27 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.58431524 |
| 28 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.57077557 |
| 29 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.56933925 |
| 30 | AR_20517297_ChIP-Seq_VCAP_Human | 1.56646303 |
| 31 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.53901787 |
| 32 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.53841993 |
| 33 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.52136029 |
| 34 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.51962504 |
| 35 | FUS_26573619_Chip-Seq_HEK293_Human | 1.51392088 |
| 36 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.50355400 |
| 37 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.47717273 |
| 38 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 1.47236609 |
| 39 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.47098669 |
| 40 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.46757216 |
| 41 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.44057460 |
| 42 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.43699857 |
| 43 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.43094188 |
| 44 | GATA3_26560356_Chip-Seq_TH2_Human | 1.41771612 |
| 45 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.41513535 |
| 46 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.41245425 |
| 47 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.40670137 |
| 48 | P300_19829295_ChIP-Seq_ESCs_Human | 1.38940257 |
| 49 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 1.38624936 |
| 50 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.37841135 |
| 51 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.36952028 |
| 52 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.36247189 |
| 53 | MYB_26560356_Chip-Seq_TH2_Human | 1.34979265 |
| 54 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 1.34211438 |
| 55 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.33661421 |
| 56 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.31801611 |
| 57 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.31373058 |
| 58 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.31120197 |
| 59 | ETV1_20927104_ChIP-Seq_GIST48_Human | 1.29816559 |
| 60 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.29806706 |
| 61 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.29441386 |
| 62 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.28487302 |
| 63 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.27768394 |
| 64 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.26251540 |
| 65 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.25344122 |
| 66 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.23079834 |
| 67 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.22747717 |
| 68 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.22390064 |
| 69 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.20201865 |
| 70 | NCOR_22424771_ChIP-Seq_293T_Human | 1.19718157 |
| 71 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.17756853 |
| 72 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.17312866 |
| 73 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.16585618 |
| 74 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.16143597 |
| 75 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.15553584 |
| 76 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.14925567 |
| 77 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.14901980 |
| 78 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.13837165 |
| 79 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.12472177 |
| 80 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.12182156 |
| 81 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.12134189 |
| 82 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.12134189 |
| 83 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.11451359 |
| 84 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.08360244 |
| 85 | AR_25329375_ChIP-Seq_VCAP_Human | 1.08127637 |
| 86 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.07548019 |
| 87 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.06806462 |
| 88 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.06256946 |
| 89 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.06250751 |
| 90 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.06203347 |
| 91 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.06203347 |
| 92 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.05530240 |
| 93 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.05331382 |
| 94 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.05292360 |
| 95 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.05133472 |
| 96 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.04882753 |
| 97 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.04528667 |
| 98 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04267418 |
| 99 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.03889352 |
| 100 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.02778011 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003195_calcinosis | 5.42460574 |
| 2 | MP0000372_irregular_coat_pigmentation | 3.64195527 |
| 3 | MP0005171_absent_coat_pigmentation | 3.59539762 |
| 4 | MP0008058_abnormal_DNA_repair | 3.40703457 |
| 5 | MP0003136_yellow_coat_color | 3.21936239 |
| 6 | MP0001873_stomach_inflammation | 2.98211333 |
| 7 | MP0009697_abnormal_copulation | 2.85967570 |
| 8 | MP0006072_abnormal_retinal_apoptosis | 2.52138228 |
| 9 | MP0008877_abnormal_DNA_methylation | 2.43438167 |
| 10 | MP0005671_abnormal_response_to | 2.42242635 |
| 11 | MP0005174_abnormal_tail_pigmentation | 2.23889995 |
| 12 | MP0008995_early_reproductive_senescence | 2.19378504 |
| 13 | MP0002837_dystrophic_cardiac_calcinosis | 2.18734542 |
| 14 | MP0000015_abnormal_ear_pigmentation | 2.05135321 |
| 15 | MP0002638_abnormal_pupillary_reflex | 2.04775392 |
| 16 | MP0000569_abnormal_digit_pigmentation | 1.99243435 |
| 17 | MP0004381_abnormal_hair_follicle | 1.97753138 |
| 18 | MP0004043_abnormal_pH_regulation | 1.91518670 |
| 19 | MP0005646_abnormal_pituitary_gland | 1.90641354 |
| 20 | MP0002166_altered_tumor_susceptibility | 1.85540734 |
| 21 | MP0005085_abnormal_gallbladder_physiolo | 1.60628231 |
| 22 | MP0001986_abnormal_taste_sensitivity | 1.59788253 |
| 23 | MP0009333_abnormal_splenocyte_physiolog | 1.55415248 |
| 24 | MP0005084_abnormal_gallbladder_morpholo | 1.54040795 |
| 25 | MP0005551_abnormal_eye_electrophysiolog | 1.50225614 |
| 26 | MP0002277_abnormal_respiratory_mucosa | 1.43718651 |
| 27 | MP0002102_abnormal_ear_morphology | 1.32333331 |
| 28 | MP0001984_abnormal_olfaction | 1.31845362 |
| 29 | MP0001835_abnormal_antigen_presentation | 1.30263598 |
| 30 | MP0005253_abnormal_eye_physiology | 1.28633418 |
| 31 | MP0002095_abnormal_skin_pigmentation | 1.23820937 |
| 32 | MP0006276_abnormal_autonomic_nervous | 1.23129317 |
| 33 | MP0001501_abnormal_sleep_pattern | 1.22361937 |
| 34 | MP0002009_preneoplasia | 1.22247056 |
| 35 | MP0001968_abnormal_touch/_nociception | 1.20879874 |
| 36 | MP0000465_gastrointestinal_hemorrhage | 1.19550096 |
| 37 | MP0002736_abnormal_nociception_after | 1.17579018 |
| 38 | MP0005360_urolithiasis | 1.15936187 |
| 39 | MP0002006_tumorigenesis | 1.13422363 |
| 40 | MP0003137_abnormal_impulse_conducting | 1.10920403 |
| 41 | MP0009745_abnormal_behavioral_response | 1.10084700 |
| 42 | MP0001905_abnormal_dopamine_level | 1.09071034 |
| 43 | MP0002877_abnormal_melanocyte_morpholog | 1.09041060 |
| 44 | MP0005645_abnormal_hypothalamus_physiol | 1.08795272 |
| 45 | MP0006082_CNS_inflammation | 1.05475842 |
| 46 | MP0003638_abnormal_response/metabolism_ | 1.04847167 |
| 47 | MP0002272_abnormal_nervous_system | 1.03411244 |
| 48 | MP0009046_muscle_twitch | 1.03249074 |
| 49 | MP0005332_abnormal_amino_acid | 1.03131934 |
| 50 | MP0003718_maternal_effect | 1.02708230 |
| 51 | MP0003763_abnormal_thymus_physiology | 1.01093890 |
| 52 | MP0002405_respiratory_system_inflammati | 0.97548013 |
| 53 | MP0005365_abnormal_bile_salt | 0.95940374 |
| 54 | MP0008961_abnormal_basal_metabolism | 0.94845268 |
| 55 | MP0005083_abnormal_biliary_tract | 0.94570248 |
| 56 | MP0006036_abnormal_mitochondrial_physio | 0.92128008 |
| 57 | MP0009785_altered_susceptibility_to | 0.91621147 |
| 58 | MP0001800_abnormal_humoral_immune | 0.90142904 |
| 59 | MP0005075_abnormal_melanosome_morpholog | 0.88801982 |
| 60 | MP0005647_abnormal_sex_gland | 0.88066241 |
| 61 | MP0003252_abnormal_bile_duct | 0.87681842 |
| 62 | MP0004142_abnormal_muscle_tone | 0.87508762 |
| 63 | MP0001661_extended_life_span | 0.86714584 |
| 64 | MP0002933_joint_inflammation | 0.86562857 |
| 65 | MP0001486_abnormal_startle_reflex | 0.86343933 |
| 66 | MP0005000_abnormal_immune_tolerance | 0.85827817 |
| 67 | MP0001440_abnormal_grooming_behavior | 0.83866593 |
| 68 | MP0009763_increased_sensitivity_to | 0.83004737 |
| 69 | MP0004134_abnormal_chest_morphology | 0.82350115 |
| 70 | MP0002653_abnormal_ependyma_morphology | 0.82031067 |
| 71 | MP0004145_abnormal_muscle_electrophysio | 0.81891689 |
| 72 | MP0001663_abnormal_digestive_system | 0.80833425 |
| 73 | MP0003315_abnormal_perineum_morphology | 0.80533028 |
| 74 | MP0002928_abnormal_bile_duct | 0.80131147 |
| 75 | MP0002229_neurodegeneration | 0.79870080 |
| 76 | MP0003879_abnormal_hair_cell | 0.78057565 |
| 77 | MP0002572_abnormal_emotion/affect_behav | 0.77647429 |
| 78 | MP0005310_abnormal_salivary_gland | 0.75630137 |
| 79 | MP0002148_abnormal_hypersensitivity_rea | 0.75300973 |
| 80 | MP0005187_abnormal_penis_morphology | 0.75011559 |
| 81 | MP0002160_abnormal_reproductive_system | 0.74919663 |
| 82 | MP0008872_abnormal_physiological_respon | 0.74349626 |
| 83 | MP0003787_abnormal_imprinting | 0.72712193 |
| 84 | MP0005389_reproductive_system_phenotype | 0.72588061 |
| 85 | MP0001542_abnormal_bone_strength | 0.70195239 |
| 86 | MP0002557_abnormal_social/conspecific_i | 0.69383376 |
| 87 | MP0001929_abnormal_gametogenesis | 0.68616027 |
| 88 | MP0000689_abnormal_spleen_morphology | 0.67010792 |
| 89 | MP0002723_abnormal_immune_serum | 0.66505563 |
| 90 | MP0002420_abnormal_adaptive_immunity | 0.66458795 |
| 91 | MP0001191_abnormal_skin_condition | 0.65799595 |
| 92 | MP0001188_hyperpigmentation | 0.64702352 |
| 93 | MP0005410_abnormal_fertilization | 0.64509196 |
| 94 | MP0005535_abnormal_body_temperature | 0.64397534 |
| 95 | MP0004147_increased_porphyrin_level | 0.63462620 |
| 96 | MP0005367_renal/urinary_system_phenotyp | 0.63153193 |
| 97 | MP0000516_abnormal_urinary_system | 0.63153193 |
| 98 | MP0002452_abnormal_antigen_presenting | 0.62877330 |
| 99 | MP0000013_abnormal_adipose_tissue | 0.62727231 |
| 100 | MP0003866_abnormal_defecation | 0.62699406 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Aplastic anemia (HP:0001915) | 4.34289800 |
| 2 | Molar tooth sign on MRI (HP:0002419) | 4.24291610 |
| 3 | Abnormality of midbrain morphology (HP:0002418) | 4.24291610 |
| 4 | Pancreatic cysts (HP:0001737) | 3.64649134 |
| 5 | Posterior subcapsular cataract (HP:0007787) | 3.58021862 |
| 6 | Abnormality of the fovea (HP:0000493) | 3.46678682 |
| 7 | Limb dystonia (HP:0002451) | 3.44456516 |
| 8 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 3.37281799 |
| 9 | Hypoplasia of the fovea (HP:0007750) | 3.37281799 |
| 10 | Hypothermia (HP:0002045) | 3.24180219 |
| 11 | Microretrognathia (HP:0000308) | 3.16562585 |
| 12 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.86338712 |
| 13 | Hypoproteinemia (HP:0003075) | 2.82917000 |
| 14 | 3-Methylglutaconic aciduria (HP:0003535) | 2.79610376 |
| 15 | Delusions (HP:0000746) | 2.74753888 |
| 16 | Intrahepatic cholestasis (HP:0001406) | 2.71759925 |
| 17 | Sensorimotor neuropathy (HP:0007141) | 2.70355177 |
| 18 | Abnormality of the prostate (HP:0008775) | 2.68714982 |
| 19 | Methylmalonic acidemia (HP:0002912) | 2.65114802 |
| 20 | Decreased central vision (HP:0007663) | 2.62127904 |
| 21 | Abnormality of alanine metabolism (HP:0010916) | 2.60566634 |
| 22 | Hyperalaninemia (HP:0003348) | 2.60566634 |
| 23 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.60566634 |
| 24 | Congenital sensorineural hearing impairment (HP:0008527) | 2.59800250 |
| 25 | Lip pit (HP:0100267) | 2.56898094 |
| 26 | Abnormality of macular pigmentation (HP:0008002) | 2.51990610 |
| 27 | Attenuation of retinal blood vessels (HP:0007843) | 2.47601820 |
| 28 | Gastrointestinal infarctions (HP:0005244) | 2.44616021 |
| 29 | Cystic liver disease (HP:0006706) | 2.43711709 |
| 30 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.42624542 |
| 31 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.36643069 |
| 32 | Spastic paraparesis (HP:0002313) | 2.31791714 |
| 33 | Absent speech (HP:0001344) | 2.30199400 |
| 34 | Ileus (HP:0002595) | 2.29930557 |
| 35 | Stomach cancer (HP:0012126) | 2.26380365 |
| 36 | Unsteady gait (HP:0002317) | 2.25958763 |
| 37 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.23899238 |
| 38 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 2.22864199 |
| 39 | Hyperglycinuria (HP:0003108) | 2.22711641 |
| 40 | Hypoplasia of the uterus (HP:0000013) | 2.19681159 |
| 41 | Tetraparesis (HP:0002273) | 2.19493384 |
| 42 | Submucous cleft hard palate (HP:0000176) | 2.18083298 |
| 43 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.17866324 |
| 44 | Abnormality of glycine metabolism (HP:0010895) | 2.17866324 |
| 45 | Albinism (HP:0001022) | 2.14494576 |
| 46 | Reduced antithrombin III activity (HP:0001976) | 2.14429624 |
| 47 | Congenital stationary night blindness (HP:0007642) | 2.10991981 |
| 48 | True hermaphroditism (HP:0010459) | 2.10167818 |
| 49 | Pancreatic fibrosis (HP:0100732) | 2.09422196 |
| 50 | Abnormal protein glycosylation (HP:0012346) | 2.08905351 |
| 51 | Abnormal glycosylation (HP:0012345) | 2.08905351 |
| 52 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.08905351 |
| 53 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.08905351 |
| 54 | Cutaneous melanoma (HP:0012056) | 2.08426810 |
| 55 | Acute necrotizing encephalopathy (HP:0006965) | 2.06531169 |
| 56 | Generalized aminoaciduria (HP:0002909) | 2.05298294 |
| 57 | Optic disc pallor (HP:0000543) | 2.04378530 |
| 58 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.04375041 |
| 59 | Cerebral hypomyelination (HP:0006808) | 2.02923152 |
| 60 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.02513162 |
| 61 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.02369080 |
| 62 | Abnormality of vitamin B metabolism (HP:0004340) | 2.01508258 |
| 63 | Pendular nystagmus (HP:0012043) | 2.01114546 |
| 64 | Increased serum pyruvate (HP:0003542) | 2.00820010 |
| 65 | Amyotrophic lateral sclerosis (HP:0007354) | 1.97586979 |
| 66 | Concave nail (HP:0001598) | 1.91064319 |
| 67 | Thyroiditis (HP:0100646) | 1.90884013 |
| 68 | Patchy hypopigmentation of hair (HP:0011365) | 1.89901411 |
| 69 | Broad alveolar ridges (HP:0000187) | 1.89594924 |
| 70 | Methylmalonic aciduria (HP:0012120) | 1.88532398 |
| 71 | Abnormality of urine glucose concentration (HP:0011016) | 1.88158155 |
| 72 | Glycosuria (HP:0003076) | 1.88158155 |
| 73 | Nephrogenic diabetes insipidus (HP:0009806) | 1.87965407 |
| 74 | Autoimmune hemolytic anemia (HP:0001890) | 1.86581917 |
| 75 | Hyperammonemia (HP:0001987) | 1.86266950 |
| 76 | Colon cancer (HP:0003003) | 1.85273780 |
| 77 | Progressive macrocephaly (HP:0004481) | 1.84912576 |
| 78 | Lethargy (HP:0001254) | 1.83699217 |
| 79 | Dyskinesia (HP:0100660) | 1.83400721 |
| 80 | Type I transferrin isoform profile (HP:0003642) | 1.83289560 |
| 81 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.83032052 |
| 82 | Nephronophthisis (HP:0000090) | 1.82930384 |
| 83 | Severe combined immunodeficiency (HP:0004430) | 1.82691819 |
| 84 | Cerebral edema (HP:0002181) | 1.82540735 |
| 85 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.81295813 |
| 86 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.81295813 |
| 87 | Abnormality of glycolipid metabolism (HP:0010969) | 1.81295813 |
| 88 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.80704375 |
| 89 | Nausea (HP:0002018) | 1.80244081 |
| 90 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.79615990 |
| 91 | Agitation (HP:0000713) | 1.78047377 |
| 92 | Encephalitis (HP:0002383) | 1.77780313 |
| 93 | Gangrene (HP:0100758) | 1.77244014 |
| 94 | Lissencephaly (HP:0001339) | 1.72669369 |
| 95 | Type II lissencephaly (HP:0007260) | 1.72149401 |
| 96 | Anhidrosis (HP:0000970) | 1.72040362 |
| 97 | Abnormality of binocular vision (HP:0011514) | 1.71648729 |
| 98 | Diplopia (HP:0000651) | 1.71648729 |
| 99 | Abolished electroretinogram (ERG) (HP:0000550) | 1.70135040 |
| 100 | Increased hepatocellular lipid droplets (HP:0006565) | 1.69233956 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 4.49932905 |
| 2 | MUSK | 3.62321958 |
| 3 | NUAK1 | 3.55469273 |
| 4 | PAK3 | 3.08350493 |
| 5 | FRK | 2.80622249 |
| 6 | FER | 2.70955254 |
| 7 | TRIM28 | 2.43270484 |
| 8 | AKT3 | 2.34620662 |
| 9 | TAOK3 | 2.26631303 |
| 10 | MAP3K6 | 2.14802414 |
| 11 | FES | 2.09336013 |
| 12 | MKNK1 | 1.93314548 |
| 13 | NEK1 | 1.93281557 |
| 14 | GRK6 | 1.86379319 |
| 15 | KDR | 1.71168808 |
| 16 | GRK7 | 1.64725573 |
| 17 | RAF1 | 1.58470097 |
| 18 | PDK2 | 1.56147532 |
| 19 | TLK1 | 1.55691655 |
| 20 | BCR | 1.52383457 |
| 21 | EIF2AK3 | 1.52219542 |
| 22 | GRK1 | 1.48277912 |
| 23 | PAK6 | 1.46584793 |
| 24 | MAPKAPK5 | 1.46442558 |
| 25 | TESK2 | 1.42788906 |
| 26 | MARK3 | 1.31623969 |
| 27 | CSNK1G2 | 1.30554693 |
| 28 | CSNK1G3 | 1.30209312 |
| 29 | ADRBK2 | 1.29463768 |
| 30 | ERBB3 | 1.28385983 |
| 31 | VRK1 | 1.24974921 |
| 32 | RPS6KA4 | 1.22766779 |
| 33 | MAP2K1 | 1.21672410 |
| 34 | PRKCI | 1.13445419 |
| 35 | PINK1 | 1.10252731 |
| 36 | MKNK2 | 1.08170530 |
| 37 | DMPK | 1.06545862 |
| 38 | PLK2 | 1.04025691 |
| 39 | ZAK | 1.01679942 |
| 40 | DYRK3 | 0.99983521 |
| 41 | STK38 | 0.99373636 |
| 42 | TYRO3 | 0.98524699 |
| 43 | MATK | 0.97232408 |
| 44 | CSNK1G1 | 0.95942875 |
| 45 | CSK | 0.95875081 |
| 46 | TAOK1 | 0.91320983 |
| 47 | VRK2 | 0.88009261 |
| 48 | CSNK1A1L | 0.87345841 |
| 49 | PLK3 | 0.85687138 |
| 50 | RPS6KA5 | 0.84646171 |
| 51 | LCK | 0.83085378 |
| 52 | PIM2 | 0.82576691 |
| 53 | PRKCE | 0.81560144 |
| 54 | MAP3K5 | 0.79714075 |
| 55 | MAPK13 | 0.77463657 |
| 56 | SIK3 | 0.73573143 |
| 57 | WNK3 | 0.72081058 |
| 58 | INSRR | 0.71510856 |
| 59 | TSSK6 | 0.70284398 |
| 60 | STK16 | 0.70273346 |
| 61 | CAMKK2 | 0.67214639 |
| 62 | FGFR1 | 0.65087789 |
| 63 | BCKDK | 0.65014828 |
| 64 | ADRBK1 | 0.62458147 |
| 65 | GRK5 | 0.61457530 |
| 66 | MAP4K2 | 0.59602353 |
| 67 | STK3 | 0.58832659 |
| 68 | CAMK2A | 0.57588879 |
| 69 | PHKG1 | 0.56412343 |
| 70 | PHKG2 | 0.56412343 |
| 71 | PAK1 | 0.51692631 |
| 72 | EGFR | 0.51150338 |
| 73 | PIM1 | 0.51101556 |
| 74 | ABL1 | 0.50774487 |
| 75 | MINK1 | 0.50305513 |
| 76 | TRPM7 | 0.50207223 |
| 77 | PRKCH | 0.49094524 |
| 78 | PIK3CA | 0.48768186 |
| 79 | IGF1R | 0.46133918 |
| 80 | DAPK2 | 0.45366978 |
| 81 | PRKACG | 0.43593342 |
| 82 | BRSK1 | 0.43382192 |
| 83 | OXSR1 | 0.42322867 |
| 84 | MAP3K2 | 0.40968060 |
| 85 | MST4 | 0.40803018 |
| 86 | STK38L | 0.39321376 |
| 87 | PRKACA | 0.39065768 |
| 88 | PRKAA1 | 0.36930581 |
| 89 | PRKCQ | 0.35409039 |
| 90 | WNK4 | 0.34666888 |
| 91 | PRKCA | 0.34626245 |
| 92 | TNK2 | 0.34359775 |
| 93 | PLK4 | 0.33821485 |
| 94 | PRKCG | 0.33557866 |
| 95 | MAPK3 | 0.32920217 |
| 96 | PRKD2 | 0.32253804 |
| 97 | RPS6KA1 | 0.31910064 |
| 98 | FGR | 0.31585384 |
| 99 | PRKG1 | 0.31056605 |
| 100 | SYK | 0.30920456 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fatty acid elongation_Homo sapiens_hsa00062 | 4.15465366 |
| 2 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 3.43424999 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 2.98172121 |
| 4 | RNA polymerase_Homo sapiens_hsa03020 | 2.70966236 |
| 5 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.69118989 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.50967773 |
| 7 | Protein export_Homo sapiens_hsa03060 | 2.19804321 |
| 8 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.19082283 |
| 9 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.07716569 |
| 10 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.01669091 |
| 11 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.00640907 |
| 12 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.96797335 |
| 13 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.96463814 |
| 14 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.90073614 |
| 15 | Phototransduction_Homo sapiens_hsa04744 | 1.87794278 |
| 16 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.73820097 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.72360596 |
| 18 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.70703435 |
| 19 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.64708377 |
| 20 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.59384623 |
| 21 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.59003583 |
| 22 | Parkinsons disease_Homo sapiens_hsa05012 | 1.58757384 |
| 23 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.54314717 |
| 24 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.50893013 |
| 25 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.48096286 |
| 26 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.40973145 |
| 27 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.36127905 |
| 28 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.35676549 |
| 29 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.32243972 |
| 30 | Basal transcription factors_Homo sapiens_hsa03022 | 1.31430299 |
| 31 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.29025070 |
| 32 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.27840510 |
| 33 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.20954835 |
| 34 | Peroxisome_Homo sapiens_hsa04146 | 1.20948200 |
| 35 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.19547195 |
| 36 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.19358667 |
| 37 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.18125500 |
| 38 | Other glycan degradation_Homo sapiens_hsa00511 | 1.16413131 |
| 39 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.06747533 |
| 40 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.05658460 |
| 41 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.04290059 |
| 42 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.01618039 |
| 43 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.00732051 |
| 44 | Allograft rejection_Homo sapiens_hsa05330 | 1.00337892 |
| 45 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.99602516 |
| 46 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.99530837 |
| 47 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.99446879 |
| 48 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.96876697 |
| 49 | Shigellosis_Homo sapiens_hsa05131 | 0.94922397 |
| 50 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.91281591 |
| 51 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.88854800 |
| 52 | Alzheimers disease_Homo sapiens_hsa05010 | 0.87935079 |
| 53 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.87170181 |
| 54 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.86735262 |
| 55 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.86073488 |
| 56 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.85750273 |
| 57 | Olfactory transduction_Homo sapiens_hsa04740 | 0.85721542 |
| 58 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.85548811 |
| 59 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.82995013 |
| 60 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.80813711 |
| 61 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.80764089 |
| 62 | Asthma_Homo sapiens_hsa05310 | 0.74157409 |
| 63 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.70762692 |
| 64 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.70548740 |
| 65 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.70359110 |
| 66 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.69379547 |
| 67 | Viral myocarditis_Homo sapiens_hsa05416 | 0.68375054 |
| 68 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.66607835 |
| 69 | Taste transduction_Homo sapiens_hsa04742 | 0.64205705 |
| 70 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.61894778 |
| 71 | Long-term depression_Homo sapiens_hsa04730 | 0.61374111 |
| 72 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.60077507 |
| 73 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.56978665 |
| 74 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.56655829 |
| 75 | Huntingtons disease_Homo sapiens_hsa05016 | 0.55932169 |
| 76 | Metabolic pathways_Homo sapiens_hsa01100 | 0.54305094 |
| 77 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.54239622 |
| 78 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.52157163 |
| 79 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.50977925 |
| 80 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.50465944 |
| 81 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.49727716 |
| 82 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.49051859 |
| 83 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.48751495 |
| 84 | ABC transporters_Homo sapiens_hsa02010 | 0.44057622 |
| 85 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.43813608 |
| 86 | Spliceosome_Homo sapiens_hsa03040 | 0.41926137 |
| 87 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.40415721 |
| 88 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.40159756 |
| 89 | Retinol metabolism_Homo sapiens_hsa00830 | 0.37287881 |
| 90 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.37130529 |
| 91 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.36719875 |
| 92 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.36144263 |
| 93 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.35230193 |
| 94 | Nicotine addiction_Homo sapiens_hsa05033 | 0.35170764 |
| 95 | Salivary secretion_Homo sapiens_hsa04970 | 0.34859959 |
| 96 | Circadian rhythm_Homo sapiens_hsa04710 | 0.34761788 |
| 97 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.32309609 |
| 98 | RNA transport_Homo sapiens_hsa03013 | 0.31534971 |
| 99 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.30487779 |
| 100 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.30099868 |

